Quote | GoodRx Holdings Inc. (NASDAQ:GDRX)
Last: | $7.82 |
---|---|
Change Percent: | 0.77% |
Open: | $7.76 |
Close: | $7.82 |
High: | $7.87 |
Low: | $7.645 |
Volume: | 835,965 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | GoodRx Holdings Inc. (NASDAQ:GDRX)
2024-06-29 15:44:55 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk Breaks Out To An All-Time High On China Approval Of Wegovy Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis) Eli Lilly: The Party Is Probably Nearing The End ...
Consumers have paid $21 billion out-of-pocket on prescription medications in 2024, an average of $16.26 per prescription Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., debuted its new Prescription Cost Tracker where it will monitor out-of-po...
Message Board Posts | GoodRx Holdings Inc. (NASDAQ:GDRX)
Subject | By | Source | When |
---|---|---|---|
GDRX bounced can it break the resistance | Monksdream | investorshub | 07/12/2023 6:38:41 PM |
good read | @LaughinPaulRyan | investorshub | 07/10/2023 8:49:11 AM |
$GDRX we got news | TREND1 | investorshub | 07/09/2023 4:58:36 AM |
MomentumIts now up | TREND1 | investorshub | 07/08/2023 2:45:49 AM |
$GDRX should we be shorting? | @LaughinPaulRyan | investorshub | 07/03/2023 6:32:02 AM |
News, Short Squeeze, Breakout and More Instantly...
Consumers have paid $21 billion out-of-pocket on prescription medications in 2024, an average of $16.26 per prescription Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., debuted its new Prescription Cost Tracker where it will monitor out-of-po...
2024-06-10 07:00:04 ET Craig Hettenbach from Morgan Stanley issued a price target of $9.50 for GDRX on 2024-06-10 05:32:00. The adjusted price target was set to $9.50. At the time of the announcement, GDRX was trading at $8.55. The overall price target consensus is at $1...
2024-05-31 07:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...